The Technical Analyst
Select Language :
Cidara Therapeutics Inc [CDTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Cidara Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Cidara Therapeutics Inc is listed at the  Exchange

7.64% $0.906

America/New_York / 28 mar 2024 @ 11:31


Cidara Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 82.10 mill
EPS: -0.390
P/E: -2.32
Earnings Date: Mar 27, 2024
SharesOutstanding: 90.62 mill
Avg Daily Volume: 0.526 mill
RATING 2024-03-27
B+
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Buy
P/E: Sell
Price To Book: Strong Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -2.32 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.39x
Company: PE -2.32 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.881 - 0.959

( +/- 4.24%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-15 Ward Shane Buy 120 000 Common Stock
2024-03-15 Ward Shane Buy 250 000 Employee Stock Option (right to buy)
2024-03-15 Shah Preetam Buy 108 750 Common Stock
2024-03-15 Shah Preetam Buy 217 500 Employee Stock Option (right to buy)
2024-03-15 Tari Leslie Buy 111 250 Common Stock
INSIDER POWER
89.26
Last 100 transactions
Buy: 7 175 633 | Sell: 576 273

Forecast: 13:10 - $0.950

Live Trading Signals (every 1 min)

Forecast 1: 11:40 - $0.901
Forecast 2: 12:30 - $0.935
Forecast 3: 13:10 - $0.950
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.906 (7.64% )
Volume 0.942 mill
Avg. Vol. 0.526 mill
% of Avg. Vol 179.29 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Cidara Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Cidara Therapeutics Inc

RSI

Intraday RSI14 chart for Cidara Therapeutics Inc

Last 10 Buy & Sell Signals For CDTX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Cidara Therapeutics Inc

CDTX

Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.

Last 10 Buy Signals

Date Signal @
SETHUSDMar 28 - 11:223 585.80
KDPMar 28 - 11:28$30.72
EXCMar 28 - 11:28$37.40
ETHUSDMar 28 - 11:28$3 574.03
PODDMar 28 - 11:26$169.57
SFRXETHUSDMar 28 - 11:243 817.60
PSGUSDMar 28 - 11:235.30
ASRUSDMar 28 - 11:233.14
ARKMUSDMar 28 - 11:222.76
ZTUSDMar 28 - 11:13102.26

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.